SLP (SLP) Stock Analysis

SLP (SLP) is a publicly traded company in the HEALTHCARE sector. It trades at $16.77, carries a market capitalization of $345.72M. This page summarizes the public market data, fundamentals, and frequently asked questions for SLP, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - HEALTH INFORMATION SERVICES

Exchange: NASDAQ

Key Metrics

Market Sentiment

SLP currently has a Bearish sentiment score of -0.39.

About SLP

Simulations Plus, Inc. (SLP) is a leading provider of advanced software solutions for drug discovery and development, specializing in mechanistic modeling, simulation, and predictive analysis of molecular properties. Leveraging cutting-edge artificial intelligence and machine learning technologies, the company serves pharmaceutical and biotechnology industries worldwide, enhancing the efficiency and effectiveness of drug development processes. Headquartered in Lancaster, California, Simulatio...

GNG Research Analysis

GNG Research scores SLP (SLP) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for SLP.

Frequently Asked Questions

Does SLP pay dividends?

SLP (SLP) does not currently pay a regular dividend.

What is SLP's market cap?

SLP (SLP) has a market capitalization of $345.72M with a current stock price of $16.77.